Myxothiazol, a new antibiotic interfering with respiration.

AUTOR(ES)

Thierbach, G

RESUMO

Myxothiazol, a new antibiotic from the myxobacterium Myxococcus fulvus, inhibited the growth of many yeasts and fungi at concentrations between 0.01 and 3 micrograms/ml. It was generally inactive against bacteria. The inhibitory effect was cytostatic. With Candida albicans, Saccharomyces cerevisiae, and Mucor hiemalis, the growth inhibition was neutralized by glucose. Soon after being added to a cell suspension, the compound almost completely blocked oxygen consumption.

Documentos Relacionados

• Bacterial respiration.
• Pretended paralysis requiring artificial respiration.
• Laryngotracheal obstruction complicating tracheostomy or endotracheal intubation with assisted respiration. A critical review.
• Arabidopsis alternative oxidase sustains Escherichia coli respiration.
• Tumor necrosis factor alpha inhibits hepatocyte mitochondrial respiration.